The opinion focuses on the proposal for a new funding programme on Single Market and Customs for the period 2028-2034. With € 6.2 billion (double the funding compared to the current long-term EU budget), the reinforced Single Market and Customs Programme will combine several previously standalone programmes (Single Market Programme, Customs, Customs Control Equipment Instrument, Fiscalis and the Union Anti-Fraud Programme) into one coherent strategy that should preserve EU economic security.
Υπό επεξεργασία (updated on 08/01/2026) - Bureau decision date: 22/10/2025
The Cyprus Presidency has asked the European Economic and Social Committee (EESC) to draw up an exploratory opinion aimed at analysing how affordable housing initiatives can integrate measures to reduce energy costs for families and support vulnerable households.
Υπό επεξεργασία (updated on 08/01/2026) - Bureau decision date: 15/07/2025
This opinion explores the potential of the bioeconomy and how policies can ensure its long-term competitiveness and investment security, while safeguarding nature. It will present civil society's views on further goals which include increasing resource-efficient and circular use of biological resources, securing a sustainable supply of biomass, both within the EU and from international sources, and strengthening the EU’s position in the rapidly expanding global bioeconomy.
Υπό επεξεργασία (updated on 06/01/2026) - Bureau decision date: 22/10/2025
This opinion will address the Commission's legislative initiative which aims to reduce the administrative burden without affecting the environmental objectives agreed under the existing legislation in the areas of, among others, industrial installations and circular economy, environmental assessments and permitting, chemical waste, Extended Producer Responsibility and waste management.
Υπό επεξεργασία (updated on 17/12/2025) - Bureau decision date: 16/09/2025
This initiative aims to simplify EU legislation on medical devices and diagnostics to enhance competitiveness, foster innovation and ensure proportionate, cost-effective safety requirements while maintaining high levels of patient protection and public health.
Υπό επεξεργασία (updated on 15/12/2025) - Bureau decision date: 15/07/2025
